News

Using as our lead structure a potent PKC ligand (1) that we had previously described, we investigated a series of branched DAG-lactones to optimize the scaffold for PKC binding affinity and reduced ...
Trump’s new COVID-19 website features five arguments supporting the lab. Among them was the explanation that Wuhan – the Chinese city where the virus first began spreading – is home to a ...
The Neurosciences Track is designed to introduce you to the principles of Neuroscience, including electrical and chemical communication within and between neurons, neural development, neurological ...
The details of that reorganization have now become clear and involve laying off 63% of Prothena’s workforce, the company explained in a post-market release June 18. The biotech entered 2025 with ...
As with many industries, the recent rise of artificial intelligence has impacted biotechnology in many ways. Here's what some experts and employees had to say about their current AI usage: ...
On June 18th the institute spun out its first biotech firm, Draig Therapeutics, specialising in precision neuroscience, specifically in the treatment of depression.
Biotech Fluidics has opened a new office in Haltern am See, strengthening its position in the DACH region and reinforcing its support for local labs and life science organisations. The expansion marks ...
Department of Homeland Security (DHS) Secretary Kristi Noem visited a biological hazard lab the day before she was rushed to hospital over an allergic reaction.
SK Biopharmaceuticals signed a memorandum of understanding with PhnyX Lab, a U.S.-based AI startup backed by SK Networks, to establish an AI-powered drug development framework.
In this edition of STAT's AI Prognosis newsletter: A look at what David Baker's AI biotech Xaira has been up to, and more.
Eli Lilly is on something of a tear, aiming to prove with Tuesday’s $1.3 billion acquisition of Verve Therapeutics that it’s more than just a cardio-metabolic and neuroscience company. The ...